Home/Filings/4/0001415889-25-014532
4//SEC Filing

Kalir Erez 4

Accession 0001415889-25-014532

CIK 0001817229other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 5:45 PM ET

Size

11.4 KB

Accession

0001415889-25-014532

Insider Transaction Report

Form 4
Period: 2025-05-22
Kalir Erez
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-22+30,00030,000 total
    Exercise: $0.19Exp: 2035-05-21Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 22, 2026 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.

Issuer

Vor Biopharma Inc.

CIK 0001817229

Entity typeother

Related Parties

1
  • filerCIK 0001512447

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:45 PM ET
Size
11.4 KB